Royal Philips (PHG) on Friday announced US commercial availability of its HyperVue Integrated System, a fixed, single-room configuration combining DeepOCT+NIRS intravascular imaging and X1-FFR coronary physiology assessment.
The system is designed to keep tools connected and readily available in the catheterization lab, reducing the need to move, connect, and prepare a mobile system for each procedure.
It includes continuous connectivity, a table-mounted touchscreen for bedside control, and controller updates intended to simplify setup.
Philips will showcase HyperVue Integrated alongside its broader imaging, physiology, and procedural guidance portfolio at the Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference in San Diego, Oct. 31-Nov. 3.
Comments